Prevalence and Risk Factors of Human Papillomavirus Infection in 18-Year-Old Women: Baseline Report of a Prospective Study on Human Papillomavirus Vaccine

HPV and Gynecologic Cancer

Change in Human Papillomavirus Prevalence Among U.S. Women Aged 18-59 Years, 2009-2014

Obstet Gynecol.

Berenson AB, Hirth JM, Chang M

doi: 10.1097/

HPV and Gynecologic Cancer

Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial

BMJ Open.

Ramanakumar AV, Naud P, Roteli-Martins CM, de Carvalho NS, de Borba PC, Teixeira JC, Blatter M, Moscicki AB, Harper DM, Romanowski B, Tyring SK, Ramjattan B, Schuind A, Dubin G, Franco EL; HPV-007 Study Group

doi: 10.1136/

HPV and Gynecologic Cancer

Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial

Lancet.

Huh WK, Joura EA, Giuliano AR, Iversen OE, de Andrade RP, Ault KA, Bartholomew D, Cestero RM, Fedrizzi EN, Hirschberg AL, Mayrand MH, Ruiz-Sternberg AM, Stapleton JT, Wiley DJ, Ferenczy A, Kurman R, Ronnett BM, Stoler MH, Cuzick J, Garland SM, Kjaer SK, Bautista OM, Haupt R, Moeller E, Ritter M, Roberts CC, Shields C, Luxembourg A

doi: 10.1016/

Erectile and Sexual Functions and Dysfunctions

Erectile Dysfunction in 45-Year-Old Heterosexual German Men and Associated Lifestyle Risk Factors and Comorbidities: Results From the German Male Sex Study

Sex Med.

Hallanzy J, Kron M, Goethe VE, Köhn FM, Schmautz M, Arsov C, Hadaschik B, Imkamp F, Gschwend JE, Herkommer K

doi: 10.1016/j.esxm.2018.11.004.

HPV and Gynecologic Cancer

A proper triage for detecting women with high-risk human papillomavirus genotypes other than HPV16/18

Eur J Obstet Gynecol Reprod Biol.

Wang JJ, Lyu LP, Hu QW, Wan ZQ, Dong J, Pan M, Shen WW, Zhang S

doi: 10.1016/j.ejogrb.2017.10.021.

HPV and Gynecologic Cancer

Reduction of HPV16/18 prevalence in young women after eight years of three- and two-dose vaccination schemes

Vaccine

Carnalla M, Torres-Ibarra L, Barrientos-Gutiérrez T, Cruz-Valdez A, Muñoz N, Herrero R, Stanley M, Nyitray A, Salmerón J, Lazcano-Ponce E

doi: 10.1016/j.vaccine.2021.06.040

HPV and Gynecologic Cancer

Reduction of HPV16/18 prevalence in young women after eight years of three- and two-dose vaccination schemes

Vaccine

Carnalla M, Torres-Ibarra L, Barrientos-Gutiérrez T, Cruz-Valdez A, Muñoz N, Herrero R, Stanley M, Nyitray A, Salmerón J, Lazcano-Ponce E

doi: 10.1016/j.vaccine.2021.06.040

Menopause

Body composition, cardiometabolic risk factors, physical activity, and inflammatory markers in premenopausal women after a 10-year follow-up: a MONET study

Menopause.

Razmjou S, Abdulnour J, Bastard JP, Fellahi S, Doucet É, Brochu M, Lavoie JM, Rabasa-Lhoret R, Prud'homme D

doi: 10.1097/

HPV and Gynecologic Cancer

Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis

Lancet HIV.

Kelly H, Weiss HA, Benavente Y, de Sanjose S, Mayaud P; ART and HPV Review Group

doi: 10.1016/

Related content

Change in Human Papillomavirus Prevalence Among U.S. Women Aged 18-59 Years, 2009-2014

Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial

Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial

Erectile Dysfunction in 45-Year-Old Heterosexual German Men and Associated Lifestyle Risk Factors and Comorbidities: Results From the German Male Sex Study

A proper triage for detecting women with high-risk human papillomavirus genotypes other than HPV16/18

Reduction of HPV16/18 prevalence in young women after eight years of three- and two-dose vaccination schemes

Reduction of HPV16/18 prevalence in young women after eight years of three- and two-dose vaccination schemes

Body composition, cardiometabolic risk factors, physical activity, and inflammatory markers in premenopausal women after a 10-year follow-up: a MONET study

Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis